Related Experiment Video
Updated: Apr 17, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
Premature pubarche in children with Pompe disease
Queenie K-G Tan1, David W Stockton2, Eniko Pivnick3
1Division of Medical Genetics, Department of Pediatrics, Duke University Medical Center, Durham, NC.
Abstract:
Pompe disease (PD), or glycogen storage disease type II, results from deficiency of acid α-glucosidase. Patients with infantile-onset PD die by early childhood if untreated. Patient survival has improved with enzyme replacement therapy. We report a case series of 8 patients with infantile-onset PD on enzyme replacement therapy with premature pubarche.
Related Concept Videos
Signs of Puberty
Mitral Valve Prolapse I: Introduction
Inborn Errors of Metabolism
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Lysosomal Hydrolases
Pedigree Analysis

